On February 18, 2010 Glaxo Smith Kline announced that it plans to stop selling a number of Poligrip denture cream products and also plans to remove the ingredient Zinc from its existing denture cream product line.
The announcement was reported by the Associated Press amid a growing number of lawsuits claiming that Zinc caused neurological damage and blood problems in denture cream users.
Michael E. Schmidt, Managing Partner of Schmidt & Clark, LLP (who represents a number of Poligrip users), learned of Glaxo’s decision to discontinue the use of Zinc and stated,
“I am not surprised Glaxo has made this decision today. The company is facing a growing number of lawsuits from consumers claiming to have been injured by their products. I applaud them for taking this dangerous product off the market, but for some of our clients the move comes a little too late.”